Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Lucintel | PRODUCT CODE: 1416430

Cover Image

PUBLISHER: Lucintel | PRODUCT CODE: 1416430

Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030

PUBLISHED:
PAGES: 150 - page report
DELIVERY TIME: 3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4850
PDF (2 Users License)
USD 5800
PDF (5 Users License)
USD 6700
PDF (Corporate License)
USD 8850

Add to Cart

Biomarker Trends and Forecast

The future of the global biomarker market looks promising with opportunities in the diagnostic, drug discovery & development, personalized medicine, and disease risk assessment markets. The global biomarker market is expected to reach an estimated $110.5 billion by 2030 with a CAGR of 8.8% from 2024 to 2030. The major drivers for this market are growing preference for personalized medicine and rising government support for biomarker research and development.

A more than 150-page report is developed to help in your business decisions.

Biomarker by Segment

The study includes a forecast for the global biomarker by product, type, disease indication, application, and region.

Biomarker Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Consumables
  • Services
  • Software

Biomarker Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Safety Biomarkers
  • Efficacy Biomarkers
  • Predictive Biomarkers
  • Surrogate Biomarkers
  • Pharmacodynamics Biomarkers
  • Prognostic Biomarkers
  • Validation Biomarkers

Biomarker Market by Disease Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Cancer
  • Infectious Diseases
  • Immune Disorders
  • Neurological Disorders
  • Cardiovascular Disorders
  • Others

Biomarker Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicine
  • Disease Risk Assessment
  • Others

Biomarker Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Biomarker Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biomarker companies profiled in this report include-

  • Abbott Laboratories
  • QIAGEN
  • Perkinelmer
  • Merck
  • Bio-Rad Laboratories
  • Enzo Biochem
  • Charles River Laboratories
  • Siemens
  • Epistem
  • Eurofins Scientific

Biomarker Market Insights

Lucintel forecasts that consumable will remain the largest segment over the forecast period.

Within this market, diagnostic will remain the largest segment over the forecast period.

North America will remain the largest region due to growing number of population with chronic diseases and presence of key players in the region.

Features of the Global Biomarker Market

Market Size Estimates: Biomarker Market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biomarker Market by various segments, such as by product, type, disease indication, application and region in terms of($B).

Regional Analysis: Biomarker Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, disease indications, applications, and regions for the biomarker market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biomarker market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the biomarker market size?

Answer: The global biomarker market is expected to reach an estimated $110.5 billion by 2030.

Q.2 What is the growth forecast for biomarker market?

Answer: The global biomarker market is expected to grow with a CAGR of 8.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the biomarker market?

Answer: The major drivers for this market are growing preference for personalized medicine and rising government support for biomarker research and development.

Q4. What are the major segments for biomarker market?

Answer: The future of the biomarker market looks promising with opportunities in the diagnostic, drug discovery & development, personalized medicine, and disease risk assessment markets.

Q5. Who are the key Biomarker Market companies?

Answer: Some of the key biomarker companies are as follows:

  • Abbott Laboratories
  • QIAGEN
  • PerkinElmer
  • Merck
  • Bio-Rad Laboratories
  • Enzo Biochem
  • Charles River Laboratories
  • Siemens
  • Epistem
  • Eurofins Scientific

Q6. Which biomarker market segment will be the largest in future?

Answer: Lucintel forecasts that consumable will remain the largest segment over the forecast period.

Q7. In biomarker market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing number of population with chronic diseases and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biomarker market by product (consumables, services, and software), type (safety biomarkers, efficacy biomarkers, predictive biomarkers, surrogate biomarkers, pharmacodynamics biomarkers, prognostic biomarkers, and validation biomarkers), disease indication (cancer, infectious diseases, immune disorders, neurological disorders, cardiovascular disorders, and others), application (diagnostics, drug discovery & development, personalized medicine, disease risk assessment, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biomarker Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Biomarker Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Biomarker Market by Product
    • 3.3.1: Consumables
    • 3.3.2: Services
    • 3.3.3: Software
  • 3.4: Global Biomarker Market by Type
    • 3.4.1: Safety Biomarkers
    • 3.4.2: Efficacy Biomarkers
    • 3.4.3: Predictive Biomarkers
    • 3.4.4: Surrogate Biomarkers
    • 3.4.5: Pharmacodynamics Biomarkers
    • 3.4.6: Prognostic Biomarkers
    • 3.4.7: Validation Biomarkers
  • 3.5: Global Biomarker Market by Disease Indication
    • 3.5.1: Cancer
    • 3.5.2: Infectious Diseases
    • 3.5.3: Immune Disorders
    • 3.5.4: Neurological Disorders
    • 3.5.5: Cardiovascular Disorders
    • 3.5.6: Others
  • 3.6: Global Biomarker Market by Application
    • 3.6.1: Diagnostics
    • 3.6.2: Drug Discovery & Development
    • 3.6.3: Personalized Medicine
    • 3.6.4: Disease Risk Assessment
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Biomarker Market by Region
  • 4.2: North American Biomarker Market
    • 4.2.2: North American Biomarker Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others
  • 4.3: European Biomarker Market
    • 4.3.1: European Biomarker Market by Product: Consumables, Services, and Software
    • 4.3.2: European Biomarker Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others
  • 4.4: APAC Biomarker Market
    • 4.4.1: APAC Biomarker Market by Product: Consumables, Services, and Software
    • 4.4.2: APAC Biomarker Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others
  • 4.5: ROW Biomarker Market
    • 4.5.1: ROW Biomarker Market by Product: Consumables, Services, and Software
    • 4.5.2: ROW Biomarker Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Biomarker Market by Product
    • 6.1.2: Growth Opportunities for the Global Biomarker Market by Type
    • 6.1.3: Growth Opportunities for the Global Biomarker Market by Disease Indication
    • 6.1.4: Growth Opportunities for the Global Biomarker Market by Application
    • 6.1.5: Growth Opportunities for the Global Biomarker Market by Region
  • 6.2: Emerging Trends in the Global Biomarker Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Biomarker Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biomarker Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: QIAGEN
  • 7.3: PerkinElmer
  • 7.4: Merck
  • 7.5: Bio-Rad Laboratories
  • 7.6: Enzo Biochem
  • 7.7: Charles River Laboratories
  • 7.8: Siemens
  • 7.9: Epistem
  • 7.10: Eurofins Scientific
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!